By Sheri Kasprzak
New York, Nov. 30 - Ceragenix Pharmaceuticals, Inc. said it completed a private placement of convertible promissory notes for $3.2 million.
The 10% notes were sold to four accredited investors.
The notes mature on Nov. 28, 2007 and are convertible into shares at $2.05 each.
The investors also received one warrant for every two shares issuable upon conversion of the notes. The warrants are exercisable at $2.255 each for five years.
Proceeds will be used for working capital.
Based in Denver, Ceragenix is a pharmaceutical company focused dermatological products and treatments for infections of the skin.
| Issuer: | Ceragenix Pharmaceuticals, Inc.
|
| Issue: | Convertible promissory notes
|
| Amount: | $3.2 million
|
| Maturity: | Nov. 28, 2007
|
| Coupon: | 10%
|
| Price: | Par
|
| Yield: | 10%
|
| Conversion price: | $2.05
|
| Warrants: | One warrant per two shares issuable upon conversion
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $2.255
|
| Settlement date: | Nov. 28
|
| Stock price: | $2.10 at close Nov. 28
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
